Could a liver transplant from a living donor help fight colorectal cancer that spread?

NCT ID NCT05248581

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study creates a registry to track outcomes of living donor liver transplants in adults with colorectal cancer that has spread to the liver and cannot be removed by surgery. Researchers will collect medical data to see how long patients live without the cancer returning and overall survival at 1, 3, and 5 years. The goal is to understand if this procedure can be a viable treatment option for this group of patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
living donor liver transplantation
What this could lead to
If successful, this approach could offer a new treatment option for patients with colorectal cancer that has spread to the liver and cannot be removed by standard surgery.
What could go wrong
This is a small registry study, not a controlled trial, so it cannot prove the procedure works. Liver transplant carries major risks, including rejection and lifelong anti-rejection medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Rochester Medical Center

    RECRUITING

    Rochester, New York, 14642, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.